GlassScriptPhysician profile
Mark S Hakim
NPI 1598286569
$5,797.60
in general payments reported to CMS, 2019-2025
11 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $364 · 2021: $64.97 · 2022: $1,395 · 2023: $174 · 2024: $3,109 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,822 · Food and Beverage: $1,767 · Education: $7.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,822.36 |
| Food and Beverage | $1,767.48 |
| Education | $7.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,929.32 | 2019-2025 | Acuvue |
| Coopervision INC. | $1,112.71 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $477.57 | 2022-2025 | Infuse |
| Alcon Vision LLC | $397.63 | 2020-2022 | |
| Sight Sciences, INC. | $340.10 | 2024-2025 | Omni Surgical System, Tearcare System |
| Apellis Pharmaceuticals, INC. | $120.83 | 2024 | Syfovre |
| Tarsus Pharmaceuticals, INC. | $120.40 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.00 | 2019 | |
| Carl Zeiss Meditec, INC. | $86.67 | 2019 | |
| Glaukos Corporation | $64.97 | 2021 | |
| Carl Zeiss Meditec Ag | $34.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hakim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.